205 related articles for article (PubMed ID: 21383188)
1. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis.
Angus-Hill ML; Elbert KM; Hidalgo J; Capecchi MR
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4914-9. PubMed ID: 21383188
[TBL] [Abstract][Full Text] [Related]
2. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
3. The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
[TBL] [Abstract][Full Text] [Related]
4. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
[TBL] [Abstract][Full Text] [Related]
5. GRG5/AES interacts with T-cell factor 4 (TCF4) and downregulates Wnt signaling in human cells and zebrafish embryos.
Costa AM; Pereira-Castro I; Ricardo E; Spencer F; Fisher S; da Costa LT
PLoS One; 2013; 8(7):e67694. PubMed ID: 23840876
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of peroxisome proliferator-activated receptor gamma promotes tumorigenesis through activation of the beta-catenin / T cell factor (TCF) pathway in the mouse intestine.
Fujisawa T; Sugiyama M; Tomimoto A; Wada K; Endo H; Takahashi H; Yoneda K; Yoneda M; Inamori M; Saito S; Terauchi Y; Kadowaki T; Tsuchiya N; Nakagama H; Nakajima A
J Pharmacol Sci; 2008 Dec; 108(4):535-44. PubMed ID: 19075513
[TBL] [Abstract][Full Text] [Related]
7. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
8. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
9. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
[TBL] [Abstract][Full Text] [Related]
10. Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression.
Wallmen B; Schrempp M; Hecht A
Nucleic Acids Res; 2012 Oct; 40(19):9455-69. PubMed ID: 22859735
[TBL] [Abstract][Full Text] [Related]
11. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.
Li Y; Bavarva JH; Wang Z; Guo J; Qian C; Thibodeau SN; Golemis EA; Liu W
Oncogene; 2011 Jun; 30(23):2633-43. PubMed ID: 21317929
[TBL] [Abstract][Full Text] [Related]
12. UHRF2 promotes intestinal tumorigenesis through stabilization of TCF4 mediated Wnt/β-catenin signaling.
Li L; Duan Q; Zeng Z; Zhao J; Lu J; Sun J; Zhang J; Siwko S; Wong J; Shi T; Zhang X; Liu M; Chen J; Li D
Int J Cancer; 2020 Oct; 147(8):2239-2252. PubMed ID: 32372448
[TBL] [Abstract][Full Text] [Related]
13. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer.
Guo Q; Shen S; Liao M; Lian P; Wang X
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):450-6. PubMed ID: 20705583
[TBL] [Abstract][Full Text] [Related]
14. T-cell factor (TCF/LEF1) binding elements (TBEs) of FasL (Fas ligand or CD95 ligand) bind and cluster Fas (CD95) and form complexes with the TCF-4 and b-catenin transcription factors in vitro and in vivo which result in triggering cell death and/or cell activation.
Liu X; Huang Y; Zhang Y; Li X; Liu C; Huang S; Xu D; Wu Y; Liu X
Cell Mol Neurobiol; 2016 Aug; 36(6):1001-1013. PubMed ID: 27090258
[TBL] [Abstract][Full Text] [Related]
15. β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells.
Dentice M; Luongo C; Ambrosio R; Sibilio A; Casillo A; Iaccarino A; Troncone G; Fenzi G; Larsen PR; Salvatore D
Gastroenterology; 2012 Oct; 143(4):1037-47. PubMed ID: 22771508
[TBL] [Abstract][Full Text] [Related]
16. Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.
Sakamaki A; Katsuragi Y; Otsuka K; Tomita M; Obata M; Iwasaki T; Abe M; Sato T; Ochiai M; Sakuraba Y; Aoyagi Y; Gondo Y; Sakimura K; Nakagama H; Mishima Y; Kominami R
Carcinogenesis; 2015 Jun; 36(6):622-31. PubMed ID: 25827435
[TBL] [Abstract][Full Text] [Related]
17. A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.
Najdi R; Syed A; Arce L; Theisen H; Ting JH; Atcha F; Nguyen AV; Martinez M; Holcombe RF; Edwards RA; Marsh JL; Waterman ML
Oncogene; 2009 Nov; 28(47):4133-46. PubMed ID: 19749792
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1,25-dihydroxyvitamin D3 on the Wnt pathway in non-malignant colonic cells.
Gröschel C; Aggarwal A; Tennakoon S; Höbaus J; Prinz-Wohlgenannt M; Marian B; Heffeter P; Berger W; Kállay E
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):224-30. PubMed ID: 25777538
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase IIα mediates TCF-dependent epithelial-mesenchymal transition in colon cancer.
Zhou Q; Abraham AD; Li L; Babalmorad A; Bagby S; Arcaroli JJ; Hansen RJ; Valeriote FA; Gustafson DL; Schaack J; Messersmith WA; LaBarbera DV
Oncogene; 2016 Sep; 35(38):4990-9. PubMed ID: 26947016
[TBL] [Abstract][Full Text] [Related]
20. 3D-microenvironments initiate TCF4 expression rescuing nuclear β-catenin activity in MCF-7 breast cancer cells.
Sergio S; Coluccia AML; Lemma ED; Spagnolo B; Vergara D; Maffia M; De Vittorio M; Pisanello F
Acta Biomater; 2020 Feb; 103():153-164. PubMed ID: 31843716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
